Ticker: DMAC

Company: DiaMedica Therapeutics Inc.

Person: Giuffre Randall Michael, director

Transaction date: Jan. 2, 2026

Reporting date: Jan. 6, 2026

Average share price: 8.42

Bought 6175.0 shares for 51993.5